StockWatch
·
Pharmaceuticals
Tax & Penalty24 Sept 2026, 10:13 pm

Gufic Biosciences to Pay ₹1.72 Lakh Penalty to NSE

AI Summary

Gufic Biosciences Ltd has received a rejection from NSE for its waiver application regarding a penalty of ₹1,72,000 (excluding GST) imposed for non-compliance with SEBI LODR Regulations, 2015. The penalty relates to the appointment of an additional director who had crossed the age of seventy-five without shareholder approval via special resolution. The company had previously paid a ₹8,000 penalty to BSE for a similar issue in the June 2024 quarter. Gufic Biosciences will now pay the NSE penalty by October 3, 2026, as stipulated.

Key Highlights

  • NSE rejects waiver application for ₹1.72 Lakh penalty.
  • Penalty relates to director appointment compliance issue.
  • Company to pay NSE penalty by October 3, 2026.
  • BSE had previously rejected a similar waiver application.